Y-90 Dotatoc Radiation Protection

ORAMED TRAINING MATERIALS, NEW TOOLS TO OPTIMIZE OCCUPATIONAL ...
- Good practice for the labeling of Y-90 Dotatoc, prepared by BfS (available in German and English). Topic: NM therapy for Y-90 peptide improve radiation protection practice in interven-tional radiology, cardiology and nuclear medicine. ... Fetch Full Source

MRT And Dosimetry: The EANM Perspective
1-2 Gy blood absorbed dose gave severe radiation complication in 1 of 24 cases, Barone et al found ADER in renal failure with Y-90 DOTATOC Mones et al, Ferrer et al found ADER (haematological toxicity) for Bexxar & Patient protection . Potential for further radiation therapy. ... Retrieve Doc

Hands Dose In Nuclear Medicine - KSNMMI
Y-90 2.3 0.9 11 F-18 0.63 0.25 2.3 x1.6 Therapy with Y-90 (RIT with Zevalin®; PRRT with Dotatoc radiation protection means and tools. Skin dose limit (500 mSv/y) can be exceeded by numerous workers in hospitals where RP standard is low ... Document Retrieval

Beta radiation Exposure Of Staff During And After Therapies ...
- Radiation protection and exposure in Radioimmunotherapy Radiation exposure of staff during Y-90 / Zevalin PRRT (90Y-Dotatoc) automatic fractionation absorbed dose [mGy] 1) Radiopharma. p 50 15 1.6 1.1 0.03 - 34.1 ... Read Full Source

Nucleus.iaea.org
Peptide Receptor Radionuclide Therapy (PRRNT) using Yttrium-90 DOTATOC was first administered in the year 1996 to a patient in Basel, Switzerland. The objective was to stabilize t ... Fetch Full Source

News - Welcome To The Radiological Protection Centre
Of radiation protection and to share good practice in order t op rev nf ui c ds. Lu-177 and Y-90). Current certificates are unaffected. For full details, readers are advised to consult the ARSAC RPC NEWS •Autum/Winter 2014 ... Fetch Doc

Characteristics Of The Most Frequently - Bvsabr.be
Y-90 PRRT Dotatoc® Y-90 RIT Zevalin radiation protection means and tools. Skin dose limit (500 mSv/y) can be exceeded by numerous workers in hospitals where RP standard is low There is adequate potential to further improve radiation ... View This Document

Extremity Doses Of Medical Staff For Complex Interventional ...
Extremity Doses of Medical Staff for Complex Interventional radiation protection measures, concentrated Y90 DOTATOC solution is then sterile filtered in a sterile vial containing 100 ml of saline. ... Retrieve Here

THERANOSTICS - GI-Oncology
Molecular Imaging using PET/CT and Peptide Receptor Radionuclide Therapy (PRRT) Kidney protection Tumor and organ dosimetry intra-arterial use of Y-90 DOTATATE and DOTATOC. ... Access Content

ALARA In Handling Of Beta-Emitters - Measurement Techniques ...
(Otimization of Radiation Protection Figure 4. Classification of workers for RIT with Y-90/Zevalin ALARA in Handling of Beta-Emitters - Measurement Techniques and Optimisation Last Updated Thursday, 06 October 2011 15:17 Figure 6. ... Access Doc

EANM YIM’14 “Radionuclide Therapy: New Perspectives and Treatment Optimization Y-90 DOTATOC and In-111-Phe1 Octreotide Reduces the Ionic Indium-111/114m Contaminants Assay Predict Individual Radiation Sensitivity? Annarita Ianniello ... Read Here

Radiopharmacology - Wikipedia, The Free Encyclopedia
Radiopharmacology Radiopharmacology or medicinal March 2006. Produced by the Health Protection Agency. Malabsorption. In: The Merck Manual of Geriatrics, chapter 111. Leukoscan summary of product characteristics (Tc99m-Sulesomab). Schwochau, Klaus. ... Read Article

Institut Für Medizinische Physik Im Klinikum Nürnberg
Optimisation of RAdiation Protection for MEDical StaffOptimisation of RAdiation Protection for MEDical Staff, bei Therapien mit Y-90 (DOTATOC und Zevalin®). Dabei sind die durchschnittlichen Werte der spezifischen maximalen lokalen Hautdosis (in mSv/GBq) während ... Fetch Here

Ivyspring Theraannoossttiiccss - Thno.org
For kidney protection, patients are well hy- therapy (e.g. internal radiation using Y-90 for hepatic metastases) (Y-90 DOTATOC) for the first patient treatment in Germa-ny, a number of peptides for clinical trials and for ... Document Retrieval

Barcelona, 20-22 January 2011 EXTREMITY EXPOSURE IN NUCLEAR ...
Barcelona, 20-22 January 2011. Workshop on Optimization of Radiation Protection of Medical Staff. A. Rimpler. 1, Optimisation of radiation protection standards and individual dose monitoring of staff in nuclear medicine. Classification of workers for PRRT with Y-90/Dotatoc . Mean dose Range ... Fetch Doc

Yttrium-90 - Wikipedia, The Free Encyclopedia
Yttrium-90, 90 Y, is a medically significant isotope of yttrium. [1] Yttrium-90 has a wide and valuable use in radiation therapy to treat cancer. [2. Decay. 90 Y undergoes β − decay to zirconium-90 with a half-life of ... Read Article

Phase I Trial Of Y-DOTATOC Therapy In Children And Young ...
Phase I Trial of 90Y-DOTATOC Therapy in Children and radiopharmaceutical for renal protection. Eligibility criteria included an age of 2–25 y, progressive disease, responsive to conventional radiation therapy (14), yet their response to PRRT has been promising, ... Fetch Doc

PUBLICATION OF THE SUPERIOR HEALTH COUNCIL No. 8838 Peptide ...
PUBLICATION OF THE SUPERIOR HEALTH COUNCIL No. 8838 Peptide Receptor Radionuclide Therapy radiopharmaceuticals as such with regards to radiation protection; 1 For In-111, the reference is the Krenning scale transient use of Y-90-DOTATOC), ... Access Full Source

Peptide Receptor Radionuclide Therapy (PRRT) Of ...
(Lu-177/Y-90 labeled peptides). Keywords: 99m68Ga-DOTATOC • 90Y-DOTATATE • Tc-DTPA • 177Lu-DOTATATE • CT • FDG PET deliver radiation doses to tumors, which are adequate to achieve volume reduction or even cure. ... Access Full Source

Name: Michael G - Vanderbilt University Medical Center
Brechbiel MW, Gansow OA and Steplewski Z. Comparison of Five Bifunctional Chelate Techniques for Y 90 Labeled Monoclonal Antibody Co 17 1A. Nucl Med Biol 18 Radiation Protection Dosimetry 52(1-4) implications for internal radiotherapy with 90Y-DOTATOC. Eur J Nucl Med 26(8):877 ... Fetch This Document

Potential Clinical Utility Of Peptide Receptor Radionuclide ...
A radioactive isotope (normally Lu-177 or Y-90). Follow up 68-Ga DOTATOC scan shows complete resolution of lesions in Seg III and VI (no Multiple Medical and Radiation Protection issues. Basu, Kand. HJNM 2011 Sep-Dec;14(3):320-1. ... Return Document

Slide 1
Workshop on optimization of Radiation Protection of Medical Staff. oramed specific training module for nuclear medicine. with Y-90 (RIT with Zevalin®; PRRT with Dotatoc®), I-131 . Characteristics of the most frequently used radionuclides. ... Retrieve Full Source